Linda Bain
CIK 1578407 · Chief Financial Officer · last filed 2025-06-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$197.4K
Companies
5
Total Filings
28
Lifetime Open-Market Net
-$643.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARVN | Director | 26,045 | $7.58 | $197.4K | $0 | 6 | 2025-06-27 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Chief Financial Officer | 0 | $0.06 | $0 | -$10.1K | 8 | 2023-03-30 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | — | $0.07 | — | $0 | 2 | 2022-01-31 |
| Adverum Biotechnologies, Inc. (AAVL) Delisted | Chief Financial Officer | 41,930 | — | — | -$253.7K | 6 | 2015-08-25 |
| bluebird bio, Inc. (BLUE) Delisted | VP, Fin. & Business Operations | 0 | $4.97 | $0 | -$380.1K | 6 | 2014-03-05 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-31 | VBI Vaccines Inc/BC (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-21 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-07 | VBI Vaccines Inc/BC (VBIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | ARVN | Grant (A) | — | $0 | EDGAR |
| 2021-01-26 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-12 | ARVN | Grant (A) | — | $0 | EDGAR |
| 2015-08-25 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Grant (A) | +32,930 | $0 | EDGAR |
| 2015-06-15 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$128.8K | EDGAR |
| 2015-05-13 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$9.1K | EDGAR |
| 2015-05-12 | Adverum Biotechnologies, Inc. (AAVL) Delisted | Mixed | — | -$22.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.